アジュバント療法のグローバル市場：規模・現状・予測2019-2025

• 英文タイトル：Global Adjuvant Therapy Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9NV17593 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、アジュバント療法の世界市場について調査・分析し、アジュバント療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、ホルモン療法、その他）、用途別（病院、医療機関、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のアジュバント療法市場動向 ・主要企業別マーケットシェア ・アジュバント療法の種類別市場規模2014-2019 （化学療法、放射線療法、ホルモン療法、その他） ・アジュバント療法の用途別市場規模2014-2019 （病院、医療機関、その他） ・アジュバント療法の北米市場：主要企業・種類別/用途別市場規模 ・アジュバント療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・アジュバント療法の中国市場：主要企業・種類別/用途別市場規模 ・アジュバント療法の日本国内市場：主要企業・種類別/用途別市場規模 ・アジュバント療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・アジュバント療法のインド市場：主要企業・種類別/用途別市場規模 ・アジュバント療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Merck、Bayer、Johnson & Johnson、AstraZenca、Mylan、AbbVie、Novartis） ・アジュバント療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal.In 2018, the global Adjuvant Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Adjuvant Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adjuvant Therapy development in North America, Europe and Asia-Pacific.

The key players covered in this study
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis
…

Market segment by Type, the product can be split into
Chemotherapy
Radiotherapy
Hormonotherapy
Others

Market segment by Application, split into
Hospital
Medical Institution
Others

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Adjuvant Therapy status, future forecast, growth opportunity, key market and key players.
To present the Adjuvant Therapy development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Adjuvant Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Adjuvant Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Radiotherapy
1.4.4 Hormonotherapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Adjuvant Therapy Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Medical Institution
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Adjuvant Therapy Market Size
2.2 Adjuvant Therapy Growth Trends by Regions
2.2.1 Adjuvant Therapy Market Size by Regions (2019-2025)
2.2.2 Adjuvant Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Adjuvant Therapy Market Size by by Players
3.1.1 Global Adjuvant Therapy Revenue by by Players (2014-2019)
3.1.2 Global Adjuvant Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Adjuvant Therapy Key Players Head office and Area Served
3.3 Key Players Adjuvant Therapy Product/Solution/Service
3.4 Date of Enter into Adjuvant Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Adjuvant Therapy Market Size by Type (2014-2019)
4.2 Global Adjuvant Therapy Market Size by Application (2014-2019)

5 North America
5.1 North America Adjuvant Therapy Market Size (2014-2019)
5.2 Adjuvant Therapy Key Players in North America
5.3 North America Adjuvant Therapy Market Size by Type
5.4 North America Adjuvant Therapy Market Size by Application

6 Europe
6.1 Europe Adjuvant Therapy Market Size (2014-2019)
6.2 Adjuvant Therapy Key Players in Europe
6.3 Europe Adjuvant Therapy Market Size by Type
6.4 Europe Adjuvant Therapy Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Adjuvant Therapy Market Size (2014-2019)
7.2 Adjuvant Therapy Key Players in Asia-Pacific
7.3 Asia-Pacific Adjuvant Therapy Market Size by Type
7.4 Asia-Pacific Adjuvant Therapy Market Size by Application

8 International Players Profiles
8.1 Merck
8.1.1 Merck Company Details
8.1.2 Company Description and Business Overview
8.1.3 Adjuvant Therapy Introduction
8.1.4 Merck Revenue in Adjuvant Therapy Business (2014-2019))
8.1.5 Merck Recent Development
8.2 Bayer
8.2.1 Bayer Company Details
8.2.2 Company Description and Business Overview
8.2.3 Adjuvant Therapy Introduction
8.2.4 Bayer Revenue in Adjuvant Therapy Business (2014-2019)
8.2.5 Bayer Recent Development
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Company Details
8.3.2 Company Description and Business Overview
8.3.3 Adjuvant Therapy Introduction
8.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2014-2019)
8.3.5 Johnson & Johnson Recent Development
8.4 AstraZenca
8.4.1 AstraZenca Company Details
8.4.2 Company Description and Business Overview
8.4.3 Adjuvant Therapy Introduction
8.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2014-2019)
8.4.5 AstraZenca Recent Development
8.5 Mylan
8.5.1 Mylan Company Details
8.5.2 Company Description and Business Overview
8.5.3 Adjuvant Therapy Introduction
8.5.4 Mylan Revenue in Adjuvant Therapy Business (2014-2019)
8.5.5 Mylan Recent Development
8.6 AbbVie
8.6.1 AbbVie Company Details
8.6.2 Company Description and Business Overview
8.6.3 Adjuvant Therapy Introduction
8.6.4 AbbVie Revenue in Adjuvant Therapy Business (2014-2019)
8.6.5 AbbVie Recent Development
8.7 Novartis
8.7.1 Novartis Company Details
8.7.2 Company Description and Business Overview
8.7.3 Adjuvant Therapy Introduction
8.7.4 Novartis Revenue in Adjuvant Therapy Business (2014-2019)
8.7.5 Novartis Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Adjuvant Therapy Key Market Segments
Table Key Players Adjuvant Therapy Covered
Table Global Adjuvant Therapy Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Radiotherapy Figures
Table Key Players of Radiotherapy
Figuer Hormonotherapy Figures
Table Key Players of Hormonotherapy
Figuer Others Figures
Table Key Players of Others
Table Global Adjuvant Therapy Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Adjuvant Therapy Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Medical Institution Case Studies
Figure Others Case Studies
Figure Adjuvant Therapy Report Years Considered
Figure Global Adjuvant Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Adjuvant Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Adjuvant Therapy Market Size by Regions 2019-2025 (Million US$)
Table Global Adjuvant Therapy Market Share by Regions 2014-2019
Figure Global Adjuvant Therapy Market Share by Regions 2014-2019
Figure Global Adjuvant Therapy Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Adjuvant Therapy Revenue by by Players (2014-2019) (Million US$)
Table Global Adjuvant Therapy Market Share by by Players (2014-2019)
Figure Global Adjuvant Therapy Market Share by by Players in 2018
Table Global Adjuvant Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Adjuvant Therapy Product/Solution/Service
Table Date of Enter into Adjuvant Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Adjuvant Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Adjuvant Therapy Market Size Share by Type (2014-2019)
Figure Global Adjuvant Therapy Market Size Market Share by Type (2014-2019)
Table Global Adjuvant Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Adjuvant Therapy Market Size Share by Application (2014-2019)
Figure Global Adjuvant Therapy Market Size Market Share by Application (2014-2019)
Figure Global Adjuvant Therapy Revenue Market Share by Application in 2018
Figure North America Adjuvant Therapy Market Size 2014-2019 (Million US$)
Table North America Key Players Adjuvant Therapy Revenue (2018-2019) (Million US$)
Table North America Key Players Adjuvant Therapy Market Share (2018-2019)
Table North America Adjuvant Therapy Market Size by Type 2014-2019 (Million US$)
Table North America Adjuvant Therapy Market Share by Type 2014-2019
Table North America Adjuvant Therapy Market Size by Application 2014-2019 (Million US$)
Table North America Adjuvant Therapy Market Share by Application 2014-2019
Figure Europe Adjuvant Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Adjuvant Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Adjuvant Therapy Market Share (2018-2019)
Table Europe Adjuvant Therapy Market Size by Type 2014-2019 (Million US$)
Table Europe Adjuvant Therapy Market Share by Type 2014-2019
Table Europe Adjuvant Therapy Market Size by Application 2014-2019 (Million US$)
Table Europe Adjuvant Therapy Market Share by Application 2014-2019
Figure Asia-Pacific Adjuvant Therapy Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Adjuvant Therapy Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Adjuvant Therapy Market Share (2018-2019)
Table Asia-Pacific Adjuvant Therapy Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Adjuvant Therapy Market Share by Type 2014-2019
Table Asia-Pacific Adjuvant Therapy Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Adjuvant Therapy Market Share by Application 2014-2019
Table Merck Company Details
Table Merck Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table Merck Recent Development
Table Bayer Company Details
Table Bayer Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure Bayer Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table Bayer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table Johnson & Johnson Recent Development
Table AstraZenca Company Details
Table AstraZenca Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table AstraZenca Recent Development
Table Mylan Company Details
Table Mylan Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure Mylan Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table Mylan Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table AbbVie Recent Development
Table Novartis Company Details
Table Novartis Revenue in Adjuvant Therapy Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Adjuvant Therapy Business (2014-2019)
Table Novartis Recent Development
Table Global Adjuvant Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Adjuvant Therapy Market Size Share by Regions (2019-2025)
Figure Global Adjuvant Therapy Market Size Share by Regions in 2025
Figure North America Adjuvant Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Adjuvant Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Adjuvant Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Adjuvant Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Adjuvant Therapy Market Size by Product (2019-2025)
Figure Global Adjuvant Therapy Market Size by Product in 2025
Table Global Adjuvant Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Adjuvant Therapy Market Size by Application (2019-2025)
Figure Global Adjuvant Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---